An experimental preparation from coronaviruses was created
Last reviewed: 23.04.2024
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
The test antiviral drug, according to expectations, can become a universal medicine from most varieties of coronaviruses - in particular, from such dangerous infections as SARS or BVRS.
Just a few years ago, epidemics of little-known and severe viral infections were recorded in the world. Later they were given the name of acute and Middle Eastern respiratory syndromes. The virus of SARS was detected in the early 2000s: at that time at least 800 people died from this virus. The mortality rate was then determined at 10%.
The Middle East syndrome showed itself in 2013, spreading from the Arab territories to France, Italy, Germany and South Korea. In 12 months of the epidemic, mortality was about 40% - that is, more than 60 patients from 140 infected died.
Coronaviruses are a whole family of RNA-containing viruses that have their own envelope. The genus of coronaviruses consists of a large number of various pathogenic viruses, affecting birds and mammals. These viruses can cause respiratory diseases, inflammatory processes in the liver, kidneys, intestines, heart muscle, as well as immune pathologies.
An infectious disease manifests itself as signs of an ordinary ARI: for this reason, many are slow to seek medical help, suggesting that they are dealing with an ordinary cold. However, very quickly the symptoms increase, and the cold is soon complicated by a severe form of pneumonia - besides, not responding to normal antibiotics.
Both the first and second type of syndrome are caused by genetically different viruses, representing the family of coronaviruses. These infections can affect both birds and mammals and humans.
Until today, no special vaccine or medicine has been invented that could directly affect the mutating coronavirus.
However, more recently the periodical Science Translational Medicine published information that experiments conducted on the basis of the laboratory proved the effectiveness of a test medication that affects the causative agents of SARS and BVRS.
GS-5734 is a universal particle that affects a whole list of coronaviruses. At the moment, the substance is tested for the most dangerous lethal virus - Ebola.
"The substance that we created demonstrated extensive antiviral action against most coronaviruses. The therapeutic potential of this drug is amazing: perhaps we will be able to solve many complex medical problems with it, "says Professor Mark Denison, an expert in pathology, immunobiology and microbiology, representing the medical faculty at the American University of Vanderbilt.
To date, experts continue to experiment on a new drug. They sincerely hope that in a short time it will help not only heal lethal pathologies, but also understand the complex biology of coronaviruses.
[